Valuation: Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Market Cap 8.67B 1.29B 1.14B 1.08B 978M 1.83B 124B 1.85B 12.93B 4.99B 63.27B 4.85B 4.74B 204B P/E 2026 *
85.6x
P/E 2027 * 65.5x
Enterprise Value 8.67B 1.29B 1.14B 1.08B 978M 1.83B 124B 1.85B 12.93B 4.99B 63.27B 4.85B 4.74B 204B EV / Sales 2026 *
7.95x
EV / Sales 2027 * 7x
Free-Float
62.75%
Yield 2026 *
-
Yield 2027 * -
09-20 Shandong Linuo Pharmaceutical Packaging Co., Ltd.(XSEC:301188) added to S&P Global BMI Index CI
08-24 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 9 June 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-21 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announces Annual dividend, payable on June 09, 2026 CI
04-20 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding CI
04-06 Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million. CI
03-31 Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake RE
12-15 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
12-14 Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million. CI
11-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections CI
27/10/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
09/10/25 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
1 day-1.42%
1 week-5.36%
Current month-11.24%
1 month-9.71%
3 months-47.14%
6 months+96.24%
Current year+89.77%
1 week 32.86
Extreme 32.86
37.47
1 month 30.59
Extreme 30.59
38.86
Current year 15.07
Extreme 15.07
76.3
1 year 15.07
Extreme 15.07
76.3
3 years 10.78
Extreme 10.78
76.3
5 years 10.78
Extreme 10.78
76.3
10 years 10.78
Extreme 10.78
76.3
Manager TitleAgeSince
Chief Executive Officer 46 14/04/2024
Director of Finance/CFO 45 28/11/2022
Investor Relations Contact - -
Director TitleAgeSince
Chairman 51 30/10/2025
Chairman 47 31/12/2023
Director/Board Member 54 05/04/2015
Change 5-day change 1-year change 3-year change Capi.($)
-1.42%-5.36%+94.30%+161.14% 1.31B
-0.79%-1.23%+3.48%+24.49% 3.56B
-2.10%-7.30%-26.53%-53.65% 2.5B
-1.37%-3.90%-15.95%-35.48% 1.8B
-2.42%-8.89%-56.81%-66.29% 888M
+1.01%-6.74%+49.43%+49.43% 671M
-1.85%-3.63%-17.49%-55.08% 651M
-1.48%-4.91%+35.97%+74.75% 632M
-1.89%-4.21%-20.26%-53.87% 453M
-0.21%-2.68%+69.67%+94.63% 321M
Average -1.25%-3.77%+11.58%+14.01% 1.28B
Weighted average by Cap. -1.32%-4.00%+3.75%+7.17%

Financials

2026 *2027 *
Net sales 1.09B 162M 143M 136M 123M 231M 15.59B 233M 1.63B 627M 7.96B 610M 597M 25.61B 1.24B 184M 163M 154M 140M 262M 17.7B 264M 1.85B 712M 9.04B 693M 678M 29.09B
Net income 103M 15.35M 13.55M 12.82M 11.62M 21.79M 1.47B 22.01M 154M 59.25M 752M 57.63M 56.38M 2.42B 137M 20.42M 18.02M 17.05M 15.46M 28.98M 1.96B 29.27M 204M 78.81M 1B 76.66M 74.99M 3.22B
Net Debt - -
Logo Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.
Employees
1,403
Date Price Change Volume
29/09/26 CN¥33.40 -1.42% 11,055,616
28/09/26 CN¥33.88 -4.43% 17,499,769
24/09/26 CN¥35.45 -3.83% 16,797,659
23/09/26 CN¥36.86 +4.45% 25,332,282
22/09/26 CN¥35.29 -1.70% 18,928,025

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 301188 Stock